Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring [Phase 1]
Phase 1 rollover study by Janssen Research & Development to continue study treatment and ongoing safety monitoring in patients with acute my…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Veliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma [Phase 1]
Phase 1 clinical trial evaluating veliparib in combination with cyclophosphamide and doxorubicin hydrochloride for patients with metastatic …
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study of TransCon TLR7/8 agonist with or without pembrolizumab in patients with advanced or metastatic solid tumors has been ter…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma [Phase 1]
Phase 1 trial investigating riluzole in combination with sorafenib tosylate in patients with advanced solid tumors or melanoma; the study st…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of AI-081, a bispecific antibody targeting PD-1 and VEGF, in advanced solid tumors; the trial is evaluating safety, pharmaco…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating Dazostinag as a single agent and in combination with pembrolizumab in adults with advanced o…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors [Phase 2]
Phase 2 trial of Utidelone injection for advanced or metastatic solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating safety and preliminary anti-tumor activity of Debio 0123 as monotherapy in adults with advanced solid tumors; the t…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients [Phase 1]
Phase 1 trial update of BAT8010 for injection in advanced malignant solid tumors assessing safety, tolerability, and pharmacokinetics; study…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors [Phase 1]
A first-in-human Phase 1 study evaluating the safety and tolerability of VVD-130850 in participants with advanced solid tumors and advanced …
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: A Study to Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC) Injection of Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180) [MK-3475A] In Advanced Solid Tumors (MK-3475A-C18) [Phase 1]
Phase 1 study evaluating the bioavailability of pembrolizumab when given via subcutaneous injection with berahyaluronidase alfa in patients …
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans [NA]
A clinical trial update reports the completion of a bioequivalence study evaluating Trifluridine and Tipiracil hydrochloride tablets under f…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: First In Human Study of CX-801 in Advanced Solid Tumors [Phase 1]
This update announces the first-in-human Phase 1 study of CX-801 for adults with advanced solid tumors, currently recruiting to assess safet…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors [Phase 1]
A Phase 1 study evaluating GK01 Injection in adults with advanced malignant solid tumors; the trial is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Testing Crizotinib as Potentially Targeted Treatment in Cancers With MET Genetic Changes (MATCH - Subprotocol C1) [Phase 2]
A Phase 2 MATCH subprotocol evaluating crizotinib for cancers with MET genetic alterations; results have been posted for this study.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors [Phase 1]
A Phase 1 trial of Azenosertib (ZN-c3) in participants with solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation [Phase 1]
AstraZeneca's Phase I/IIa study of AZD0022 in KRASG12D-mutant tumors has been terminated. The study enrolled adults with advanced solid tumo…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation [Phase 2]
Phase II trial of tazemetostat in solid tumors harboring ARID1A mutations has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Indian and Alaska Native Cancer Patients Living in Rural California [NA]
This clinical trial entry describes a culturally informed patient navigation program aimed at reducing delays from diagnosis to treatment fo…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: QLS5212 for Participants With Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial update for QLS5212 in participants with advanced solid tumors, currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Combining Epigenetic And Immune Therapy to Beat Cancer. [Phase 2]
A Phase 2 trial from Institut Bergonié evaluating a combination of epigenetic therapy and immunotherapy in several advanced cancers has comp…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors [Phase 1]
A Phase 1 study of CF33-hNIS (VAXINIA), an oncolytic virus, given alone or with pembrolizumab, in adults with metastatic or advanced solid t…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: A Study of onCARlytics (CF33-CD19) in Combination With Blinatumomab in Adults With Advanced or Metastatic Solid Tumors (OASIS) [Phase 1]
The Phase 1 OASIS study evaluating onCARlytics CF33-CD19 CAR-T in combination with blinatumomab in adults with advanced or metastatic solid …
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: QLS5132 Combination Therapy in Advanced Solid Tumors [Phase 1, Phase 2]
This update describes a Phase 1/2 study of QLS5132 combination therapy in multiple cancers, including gastric cancer, non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: TNFα and IL-2 Coding Oncolytic Adenovirus TILT-123 Monotherapy [Phase 1]
Phase 1 trial of TNFα and IL-2 coding oncolytic adenovirus TILT-123 as monotherapy for solid tumors has completed.